I'm talking more about drugs. Is there any analysis that might look at the cost of funding out-of-hospital pharmaceuticals versus the costs saved to the health care system by improving outcomes in those who can't afford them? Has any analysis like that been done?
On March 21st, 2016. See this statement in context.